Related Experiment Video

Updated: Jun 14, 2026

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
04:20

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on: February 9, 2024

PND-1186 FAK inhibitor selectively promotes tumor cell apoptosis in three-dimensional environments

Michael D Schaller1, Steven M Frisch

  • 1Department of Biochemistry, West Virginia University, Morgantown, WV, USA.

Cancer Biology & Therapy
|April 6, 2010
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
08:02

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Published on: May 14, 2021

Related Experiment Videos

Last Updated: Jun 14, 2026

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
04:20

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on: February 9, 2024

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
08:02

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Published on: May 14, 2021

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Articles linked to this work by shared authors, journal, and citation graph.

Graduate Students Find Content of Responsible Conduct of Research Coursework Useful.

Science and engineering ethics·2026

Anoikis resistance and cancer.

BMC cancer·2025

Molecular Signatures of CB-6644 Inhibition of the RUVBL1/2 Complex in Multiple Myeloma.

International journal of molecular sciences·2024

Grainyhead-like-2, an epithelial master programmer, promotes interferon induction and suppresses breast cancer recurrence.

Molecular immunology·2024

Efficacy of Centers of Biomedical Research Excellence (CoBRE) grants to build research capacity in underrepresented states.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2024

Training doctoral students in critical thinking and experimental design using problem-based learning.

BMC medical education·2023

Elevated miR-103b in exosomes derived from brain-metastatic triple-negative breast cancer cells remodels the brain pre-metastatic niche (PMN).

Cancer biology & therapy·2026

Fibroblast-associated TPM2 links cell-matrix remodeling to EMT-Notch signaling and gemcitabine resistance in intrahepatic cholangiocarcinoma.

Cancer biology & therapy·2026

DNA-PKcs and PARP1 at the interface between DNA damage responses and cGAS-STING signaling: context-dependent roles and therapeutic implications.

Cancer biology & therapy·2026

Thioredoxin reductase-1 facilitates cellular plasticity and stemness mediated by TGF-β1 in non-small cell lung cancer.

Cancer biology & therapy·2026

Synchronizing immunity and angiogenesis in lung adenocarcinoma: bridging biological synergy and clinical translation.

Cancer biology & therapy·2026

The molecular mechanisms of platelets in tumor invasion and metastasis: a controversial role.

Cancer biology & therapy·2026

Comparison of an Anti-αvβ3 Integrin NIR Fluorescent Probe and Indocyanin Green for Precision Resection of Naturally Occurring Sarcomas in Dogs-A Randomized Blinded Case-Controlled Pilot Study.

Veterinary and comparative oncology·2026

The impact of oral refined sugar consumption on male reproductive parameters: The role of cessation.

JBRA assisted reproduction·2026

Assessment of Apoptosis-like Cell Death in A549 Lung Cancer Cells Induced by Photoactivated Gold Shell-Isolated Nanostars.

ACS applied bio materials·2026

EZH2 Inhibition Induces a Metabolic Stress Response Sensitizing Triple-Negative Breast Cancer to Glutaminase Targeting.

Cancer research·2026

Targeting Distinct Cell Cycle Nodes Overcomes RAS Inhibitor Resistance.

Cancer research·2026

Targeting RAB27A Enhances Pembrolizumab Sensitivity and Alleviates Immune Escape via Inactivation of the PI3K/Akt/mTOR Pathway in Triple-Negative Breast Cancer.

Clinical and experimental pharmacology & physiology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us